C-type natriuretic peptide in vascular physiology and disease

Pharmacology and Therapeutics

Volumn 105, Issue 2, 2005, Pages 85-93

  Scotland, Ramona S ^a   Ahluwalia, Amrita ^b   Hobbs, Adrian J ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Endothelial dysfunction; Endothelium; Natriuretic peptide

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; NATRIURETIC PEPTIDE TYPE C; NITRIC OXIDE; PROSTACYCLIN;

ATHEROSCLEROSIS; BLOOD PRESSURE REGULATION; BLOOD VESSEL TONE; CARDIOVASCULAR DISEASE; DRUG EFFICACY; ELECTROLYTE BALANCE; FLUID BALANCE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; ISCHEMIA; NONHUMAN; PARACRINE SIGNALING; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STRUCTURE; REPERFUSION INJURY; REVIEW; VASCULAR ENDOTHELIUM;

AMINO ACID SEQUENCE; ANIMALS; BIOLOGICAL FACTORS; BLOOD VESSELS; CARDIOVASCULAR DISEASES; ENDOTHELIUM, VASCULAR; HUMANS; MOLECULAR SEQUENCE DATA; NATRIURETIC PEPTIDE, C-TYPE; NATRIURETIC PEPTIDES; RECEPTORS, NEUROPEPTIDE; SIGNAL TRANSDUCTION;

EID: 12744256779     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2004.08.011     Document Type: Review

References (73)

1. M.B. Anand-Srivastava Atrial natriuretic peptide-C receptor and membrane signalling in hypertension J Hypertens 15 8 1997 815 826
2. M.B. Anand-Srivastava, P.D. Sehl, and D.G. Lowe Cytoplasmic domain of natriuretic peptide receptor-C inhibits adenylyl cyclase. Involvement of a pertussis toxin-sensitive G protein J Biol Chem 271 32 1996 19324 19329
3. M. Banks, C.M. Wei, C.H. Kim, J.C. Burnett Jr., and V.M. Miller Mechanism of relaxations to C-type natriuretic peptide in veins Am J Physiol 271 5 Pt 2 1996 H1907 H1911
4. D.A. Barber, J.C. Burnett Jr., L.A. Fitzpatrick, G.C. Sieck, and V.M. Miller Gender and relaxation to C-type natriuretic peptide in porcine coronary arteries J Cardiovasc Pharmacol 32 1 1998 5 11
5. G. Barletta, C. Lazzeri, S. Vecchiarino, R. Del Bene, G. Messeri, and S.A. Dello Low-dose C-type natriuretic peptide does not affect cardiac and renal function in humans Hypertension 31 3 1998 802 808
6. M. Barton, J.L. Beny, L.V. d'Uscio, T. Wyss, G. Noll, and T.F. Luscher Endothelium-independent relaxation and hyperpolarization to C-type natriuretic peptide in porcine coronary arteries J Cardiovasc Pharmacol 31 3 1998 377 383
7. V. Blais, M. Fugere, J.B. Denault, K. Klarskov, R. Day, and R. Leduc Processing of proendothelin-1 by members of the subtilisin-like pro-protein convertase family FEBS Lett 524 1-3 2002 43 48
8. V. Blaise, J.P. Wolf, J. Regnard, and S. Berthelay Characterization of human platelet receptors for atrial natriuretic peptide: evidence for clearance receptors Cell Mol Biol (Noisy-le-grand) 42 8 1996 1173 1179
9. J. Brown, and Q. Chen Regional expression of natriuretic peptide receptors during the formation of arterial neointima in the rabbit Circ Res 77 5 1995 906 918
10. F. Brunner, and G. Wolkart Relaxant effect of C-type natriuretic peptide involves endothelium and nitric oxide-cGMP system in rat coronary microvasculature Cardiovasc Res 51 3 2001 577 584
11. R. Busse, G. Edwards, M. Feletou, I. Fleming, P.M. Vanhoutte, and A.H. Weston EDHF: bringing the concepts together Trends Pharmacol Sci 23 8 2002 374 380
12. P.A. Cahill, and A. Hassid ANF-C-receptor-mediated inhibition of aortic smooth muscle cell proliferation and thymidine kinase activity Am J Physiol 266 1 Pt 2 1994 R194 R203
13. V.H. Casco, J.P. Veinot, M.L. Kuroski de Bold, R.G. Masters, M.M. Stevenson, and A.J. de Bold Natriuretic peptide system gene expression in human coronary arteries J Histochem Cytochem 50 6 2002 799 809
14. S.D. Chauhan, H. Nilsson, A. Ahluwalia, and A.J. Hobbs Release of C-type natriuretic peptide accounts for the biological activity of endothelium-derived hyperpolarizing factor Proc Natl Acad Sci U S A 100 3 2003 1426 1431
15. B.M. Cheung, and M.J. Brown Plasma brain natriuretic peptide and C-type natriuretic peptide in essential hypertension J Hypertens 12 4 1994 449 454
16. T.H. Chun, H. Itoh, Y. Ogawa, N. Tamura, K. Takaya, and T. Igaki Shear stress augments expression of C-type natriuretic peptide and adrenomedullin Hypertension 29 6 1997 1296 1302
17. H. Chusho, N. Tamura, Y. Ogawa, A. Yasoda, M. Suda, and T. Miyazawa Dwarfism and early death in mice lacking C-type natriuretic peptide Proc Natl Acad Sci U S A 98 7 2001 4016 4021
18. A.L. Clavell, A.J. Stingo, C.M. Wei, D.M. Heublein, and J.C. Burnett Jr. C-type natriuretic peptide: a selective cardiovascular peptide Am J Physiol 264 2 Pt 2 1993 R290 R295
19. N.C. Davidson, C.S. Barr, and A.D. Struthers C-type natriuretic peptide. An endogenous inhibitor of vascular angiotensin-converting enzyme activity Circulation 93 6 1996 1155 1159
20. J.G. Drewett, B.M. Fendly, D.L. Garbers, and D.G. Lowe Natriuretic peptide receptor-B (guanylyl cyclase-B) mediates C-type natriuretic peptide relaxation of precontracted rat aorta J Biol Chem 270 9 1995 4668 4674
21. D. Giannessi, M.G. Andreassi, S. Del Rey, A. Clerico, M.G. Colombo, and N. Dini Possibility of age regulation of the natriuretic peptide C-receptor in human platelets J Endocrinol Invest 24 1 2001 8 16
22. S.B. Guild, and G. Cramb Characterisation of the effects of natriuretic peptides upon ACTH secretion from the mouse pituitary Mol Cell Endocrinol 152 1-2 1999 11 19
23. N. Hama, H. Itoh, G. Shirakami, S. Suga, Y. Komatsu, and T. Yoshimasa Detection of C-type natriuretic peptide in human circulation and marked increase of plasma CNP level in septic shock patients Biochem Biophys Res Commun 198 3 1994 1177 1182
24. B. Han, and Y. Hasin Cardiovascular effects of natriuretic peptides and their interrelation with endothelin-1 Cardiovasc Drugs Ther 17 1 2003 41 52
25. A.J. Hobbs Soluble guanylate cyclase: the forgotten sibling Trends Pharmacol Sci 18 12 1997 484 491
26. A.J. Hobbs, P. Foster, C. Prescott, R.S. Scotland, and A. Ahluwalia Natriuretic peptide receptor-C regulates coronary blood flow and prevents myocardial ischemia/reperfusion injury: a novel cardioprotective role for endothelium-derived C-type natriuretic peptide Circulation 110 2004 1231 1235
27. M.L. Honing, P. Smits, P.J. Morrison, J.C. Burnett Jr., and T.J. Rabelink C-type natriuretic peptide-induced vasodilation is dependent on hyperpolarization in human forearm resistance vessels Hypertension 37 4 2001 1179 1183
28. A.D. Hughes, H. Nielsen, and P.S. Sever The effect of atrial natriuretic peptide on human isolated resistance arteries Br J Pharmacol 97 4 1989 1027 1030
29. M.B. Hussain, R.J. MacAllister, and A.J. Hobbs Reciprocal regulation of cGMP-mediated vasorelaxation by soluble and particulate guanylate cyclases Am J Physiol Heart Circ Physiol 280 3 2001 H1151 H1159
30. T. Igaki, H. Itoh, S. Suga, N. Hama, Y. Ogawa, and Y. Komatsu C-type natriuretic peptide in chronic renal failure and its action in humans Kidney Int Suppl 55 1996 S144 S147
31. K. Inoue, K. Naruse, S. Yamagami, H. Mitani, N. Suzuki, and Y. Takei Four functionally distinct C-type natriuretic peptides found in fish reveal evolutionary history of the natriuretic peptide system Proc Natl Acad Sci U S A 100 17 2003 10079 10084
32. P.R. Kalra, J.R. Clague, A.P. Bolger, S.D. Anker, P.A. Poole-Wilson, and A.D. Struthers Myocardial production of C-type natriuretic peptide in chronic heart failure Circulation 107 4 2003 571 573
33. A.J. Kenny, A. Bourne, and J. Ingram Hydrolysis of human and pig brain natriuretic peptides, urodilatin, C-type natriuretic peptide and some C-receptor ligands by endopeptidase-24.11 Biochem J 291 Pt 1 1993 83 88
34. A.K. Kiemer, M.D. Lehner, T. Hartung, and A.M. Vollmar Inhibition of cyclooxygenase-2 by natriuretic peptides Endocrinology 143 3 2002 846 852
35. M. Kohno, T. Horio, K. Yokokawa, N. Kurihara, and T. Takeda C-type natriuretic peptide inhibits thrombin- and angiotensin II-stimulated endothelin release via cyclic guanosine 3′,5′-monophosphate Hypertension 19 4 1992 320 325
36. M. Kohno, K. Yokokawa, K. Yasunari, H. Kano, M. Minami, and M. Ueda Effect of natriuretic peptide family on the oxidized LDL-induced migration of human coronary artery smooth muscle cells Circ Res 81 4 1997 585 590
37. K.R. Kublickiene, C. Grunewald, M. Kublickas, B. Lindblom, N.O. Lunell, and H. Nisell Effects of atrial natriuretic peptide and cyclic guanosine monophosphate on isolated human myometrial arteries preconstricted by endothelin-1 Gynecol Obstet Invest 40 3 1995 190 194
38. E.R. Levin, D.G. Gardner, and W.K. Samson Natriuretic peptides N Engl J Med 339 5 1998 321 328
39. T. Maack Receptors of atrial natriuretic factor Annu Rev Physiol 54 1992 11 27
40. T. Maack, M. Suzuki, F.A. Almeida, D. Nussenzveig, R.M. Scarborough, and G.A. McEnroe Physiological role of silent receptors of atrial natriuretic factor Science 238 4827 1987 675 678
41. M. Madhani, R.S. Scotland, R.J. MacAllister, and A.J. Hobbs Vascular natriuretic peptide receptor-linked particulate guanylate cyclases are modulated by nitric oxide-cyclic GMP signalling Br J Pharmacol 139 7 2003 1289 1296
42. N. Matsukawa, W.J. Grzesik, N. Takahashi, K.N. Pandey, S. Pang, and M. Yamauchi The natriuretic peptide clearance receptor locally modulates the physiological effects of the natriuretic peptide system Proc Natl Acad Sci U S A 96 13 1999 7403 7408
43. N. Ohno, H. Itoh, T. Ikeda, K. Ueyama, K. Yamahara, and K. Doi Accelerated reendothelialization with suppressed thrombogenic property and neointimal hyperplasia of rabbit jugular vein grafts by adenovirus-mediated gene transfer of C-type natriuretic peptide Circulation 105 14 2002 1623 1626
44. K. Ono, T. Mannami, S. Baba, H. Tomoike, S. Suga, and N. Iwai A single-nucleotide polymorphism in C-type natriuretic peptide gene may be associated with hypertension Hypertens Res 25 5 2002 727 730
45. G. Osol, W. Halpern, B. Tesfamariam, K. Nakayama, and D. Weinberg Synthetic atrial natriuretic factor does not dilate resistance-sized arteries Hypertension 8 7 1986 606 610
46. B.A. Prins, M.J. Weber, R.M. Hu, A. Pedram, M. Daniels, and E.R. Levin Atrial natriuretic peptide inhibits mitogen-activated protein kinase through the clearance receptor. Potential role in the inhibition of astrocyte proliferation J Biol Chem 271 24 1996 14156 14162
47. A.A. Protter, A.M. Wallace, V.A. Ferraris, and R.E. Weishaar Relaxant effect of human brain natriuretic peptide on human artery and vein tissue Am J Hypertens 9 5 1996 432 436
48. J.Y. Qian, A. Haruno, Y. Asada, T. Nishida, Y. Saito, and T. Matsuda Local expression of C-type natriuretic peptide suppresses inflammation, eliminates shear stress-induced thrombosis, and prevents neointima formation through enhanced nitric oxide production in rabbit injured carotid arteries Circ Res 91 11 2002 1063 1069
49. M.W. Radomski, R.M. Palmer, and S. Moncada The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium Biochem Biophys Res Commun 148 3 1987 1482 1489
50. R.A. Rose, A.E. Lomax, C.S. Kondo, M.B. Anand-Srivastava, and W.R. Giles Effects of C-type natriuretic peptide on ionic currents in mouse sinoatrial node: a role for the NPR-C receptor Am J Physiol Heart Circ Physiol 286 5 2004 H1970 H1977
51. R. Ross Atherosclerosis-an inflammatory disease N Engl J Med 340 2 1999 115 126
52. J.I. Rotmans, H.J. Verhagen, E. Velema, D.P. De Kleijn, H.M. Van Den, and J.J. Kastelein Local overexpression of C-type natriuretic peptide ameliorates vascular adaptation of porcine hemodialysis grafts Kidney Int 65 5 2004 1897 1905
53. T. Schachner, Y. Zou, A. Oberhuber, T. Mairinger, A. Tzankov, and G. Laufer Perivascular application of C-type natriuretic peptide attenuates neointimal hyperplasia in experimental vein grafts Eur J Cardiothorac Surg 25 4 2004 585 590
54. J.A. Schirger, D.M. Heublein, H.H. Chen, O. Lisy, M. Jougasaki, and P.W. Wennberg Presence of Dendroaspis natriuretic peptide-like immunoreactivity in human plasma and its increase during human heart failure Mayo Clin Proc 74 2 1999 126 130
55. H. Schweitz, P. Vigne, D. Moinier, C. Frelin, and M. Lazdunski A new member of the natriuretic peptide family is present in the venom of the green mamba (Dendroaspis angusticeps) J Biol Chem 267 20 1992 13928 13932
56. A.A. Seymour, P.D. Mathers, B.E. Abboa-Offei, M.M. Asaad, and H. Weber Renal and depressor activity of C-natriuretic peptide in conscious monkeys: effects of enzyme inhibitors J Cardiovasc Pharmacol 28 3 1996 397 401
57. H. Shimokawa, H. Yasutake, K. Fujii, M.K. Owada, R. Nakaike, and Y. Fukumoto The importance of the hyperpolarizing mechanism increases as the vessel size decreases in endothelium-dependent relaxations in rat mesenteric circulation J Cardiovasc Pharmacol 28 5 1996 703 711
58. G. Shirakami, H. Itoh, S. Suga, Y. Komatsu, N. Hama, and K. Mori Central action of C-type natriuretic peptide on vasopressin secretion in conscious rats Neurosci Lett 159 1-2 1993 25 28
59. M. Steinmetz, R. Potthast, K. Sabrane, and M. Kuhn Diverging vasorelaxing effects of C-type natriuretic peptide in renal resistance arteries and aortas of GC-A-deficient mice Regul Pept 119 1-2 2004 31 37
60. A.J. Stingo, A.L. Clavell, D.M. Heublein, C.M. Wei, M.R. Pittelkow, and J.C. Burnett Jr. Presence of C-type natriuretic peptide in cultured human endothelial cells and plasma Am J Physiol 263 4 Pt 2 1992 H1318 H1321
61. T. Sudoh, N. Minamino, K. Kangawa, and H. Matsuo C-type natriuretic peptide (CNP): a new member of natriuretic peptide family identified in porcine brain Biochem Biophys Res Commun 168 2 1990 863 870
62. S. Suga, H. Itoh, Y. Komatsu, Y. Ogawa, N. Hama, and T. Yoshimasa Cytokine-induced C-type natriuretic peptide (CNP) secretion from vascular endothelial cells-evidence for CNP as a novel autocrine/paracrine regulator from endothelial cells Endocrinology 133 6 1993 3038 3041
63. Y. Takei Does the natriuretic peptide system exist throughout the animal and plant kingdom? Comp Biochem Physiol B Biochem Mol Biol 129 2-3 2001 559 573
64. G. Thomas Furin at the cutting edge: from protein traffic to embryogenesis and disease Nat Rev Mol Cell Biol 3 10 2002 753 766
65. A.M. Vollmar, A.L. Gerbes, M. Nemer, and R. Schulz Detection of C-type natriuretic peptide (CNP) transcript in the rat heart and immune organs Endocrinology 132 4 1993 1872 1874
66. C.M. Wei, L.L. Aarhus, V.M. Miller, and J.C. Burnett Jr. Action of C-type natriuretic peptide in isolated canine arteries and veins Am J Physiol 264 1 Pt 2 1993 H71 H73
67. P.W. Wennberg, V.M. Miller, T. Rabelink, and J.C. Burnett Jr. Further attenuation of endothelium-dependent relaxation imparted by natriuretic peptide receptor antagonism Am J Physiol 277 4 Pt 2 1999 H1618 H1621
68. K.E. Wiley, and A.P. Davenport Physiological antagonism of endothelin-1 in human conductance and resistance coronary artery Br J Pharmacol 133 4 2001 568 574
69. R.S. Wright, C.M. Wei, C.H. Kim, M. Kinoshita, Y. Matsuda, and L.L. Aarhus C-type natriuretic peptide-mediated coronary vasodilation: role of the coronary nitric oxide and particulate guanylate cyclase systems J Am Coll Cardiol 28 4 1996 1031 1038
70. S.P. Wright, T.C. Prickett, R.N. Doughty, C. Frampton, G.D. Gamble, and T.G. Yandle Amino-terminal pro-C-type natriuretic peptide in heart failure Hypertension 2003
71. C. Wu, F. Wu, J. Pan, J. Morser, and Q. Wu Furin-mediated processing of Pro-C-type natriuretic peptide J Biol Chem 278 28 2003 25847 25852
72. K. Yamahara, H. Itoh, T.H. Chun, Y. Ogawa, J. Yamashita, and N. Sawada Significance and therapeutic potential of the natriuretic peptides/cGMP/cGMP- dependent protein kinase pathway in vascular regeneration Proc Natl Acad Sci U S A 100 6 2003 3404 3409
73. W. Yan, F. Wu, J. Morser, and Q. Wu Corin, a transmembrane cardiac serine protease, acts as a pro-atrial natriuretic peptide-converting enzyme Proc Natl Acad Sci U S A 97 15 2000 8525 8529